nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1A2—Imiquimod—skin cancer	0.114	0.145	CbGbCtD
Flutamide—CYP1B1—Docetaxel—skin cancer	0.109	0.139	CbGbCtD
Flutamide—CYP1A1—Dacarbazine—skin cancer	0.107	0.136	CbGbCtD
Flutamide—CYP2C19—Vismodegib—skin cancer	0.0853	0.109	CbGbCtD
Flutamide—CYP1A2—Vemurafenib—skin cancer	0.0622	0.0793	CbGbCtD
Flutamide—CYP3A4—Temozolomide—skin cancer	0.0595	0.0758	CbGbCtD
Flutamide—CYP3A4—Imiquimod—skin cancer	0.0595	0.0758	CbGbCtD
Flutamide—CYP1A2—Dacarbazine—skin cancer	0.0477	0.0607	CbGbCtD
Flutamide—CYP3A4—Vismodegib—skin cancer	0.0413	0.0525	CbGbCtD
Flutamide—CYP3A4—Vemurafenib—skin cancer	0.0326	0.0415	CbGbCtD
Flutamide—CYP3A5—Docetaxel—skin cancer	0.0287	0.0365	CbGbCtD
Flutamide—CYP1A2—Fluorouracil—skin cancer	0.028	0.0356	CbGbCtD
Flutamide—AR—scrotum—skin cancer	0.0137	0.258	CbGeAlD
Flutamide—CYP3A4—Docetaxel—skin cancer	0.0112	0.0142	CbGbCtD
Flutamide—AR—penis—skin cancer	0.0062	0.116	CbGeAlD
Flutamide—Metastatic neoplasm—Temozolomide—skin cancer	0.00616	0.0382	CcSEcCtD
Flutamide—Proctitis—Dactinomycin—skin cancer	0.00535	0.0331	CcSEcCtD
Flutamide—Proctitis—Fluorouracil—skin cancer	0.00446	0.0276	CcSEcCtD
Flutamide—Neoplasm malignant—Vismodegib—skin cancer	0.00438	0.0271	CcSEcCtD
Flutamide—Metastatic neoplasm—Docetaxel—skin cancer	0.0041	0.0254	CcSEcCtD
Flutamide—Blood urea increased—Vismodegib—skin cancer	0.00353	0.0219	CcSEcCtD
Flutamide—AHR—nipple—skin cancer	0.00327	0.0615	CbGeAlD
Flutamide—Traumatic liver injury—Temozolomide—skin cancer	0.00317	0.0196	CcSEcCtD
Flutamide—Neoplasm malignant—Vemurafenib—skin cancer	0.00271	0.0168	CcSEcCtD
Flutamide—Herpes zoster—Imiquimod—skin cancer	0.00262	0.0162	CcSEcCtD
Flutamide—CYP1B1—hair follicle—skin cancer	0.00252	0.0473	CbGeAlD
Flutamide—CYP1A1—skin epidermis—skin cancer	0.00249	0.0468	CbGeAlD
Flutamide—Aspartate aminotransferase increased—Vismodegib—skin cancer	0.00244	0.0151	CcSEcCtD
Flutamide—Neoplasm—Vemurafenib—skin cancer	0.00209	0.0129	CcSEcCtD
Flutamide—Ulcer—Imiquimod—skin cancer	0.00208	0.0129	CcSEcCtD
Flutamide—Bullous eruption—Docetaxel—skin cancer	0.00199	0.0123	CcSEcCtD
Flutamide—Interstitial lung disease—Bleomycin—skin cancer	0.00198	0.0123	CcSEcCtD
Flutamide—AHR—mammalian vulva—skin cancer	0.00191	0.0359	CbGeAlD
Flutamide—Interstitial lung disease—Temozolomide—skin cancer	0.00167	0.0103	CcSEcCtD
Flutamide—AHR—female reproductive system—skin cancer	0.00164	0.0308	CbGeAlD
Flutamide—AR—nipple—skin cancer	0.00162	0.0304	CbGeAlD
Flutamide—Herpes zoster—Temozolomide—skin cancer	0.00157	0.00972	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00151	0.00936	CcSEcCtD
Flutamide—Ulcer—Bleomycin—skin cancer	0.00148	0.00917	CcSEcCtD
Flutamide—Liver injury—Temozolomide—skin cancer	0.0014	0.00869	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00138	0.00856	CcSEcCtD
Flutamide—Ulcer—Dactinomycin—skin cancer	0.00138	0.00855	CcSEcCtD
Flutamide—Cystitis noninfective—Bleomycin—skin cancer	0.00137	0.00847	CcSEcCtD
Flutamide—Cystitis—Bleomycin—skin cancer	0.00135	0.00837	CcSEcCtD
Flutamide—Photosensitivity reaction—Vemurafenib—skin cancer	0.00132	0.0082	CcSEcCtD
Flutamide—Skin disorder—Vismodegib—skin cancer	0.0013	0.00803	CcSEcCtD
Flutamide—Bladder pain—Bleomycin—skin cancer	0.00127	0.00784	CcSEcCtD
Flutamide—CYP1A2—nipple—skin cancer	0.00122	0.023	CbGeAlD
Flutamide—CYP1B1—connective tissue—skin cancer	0.00121	0.0227	CbGeAlD
Flutamide—CYP1A1—nipple—skin cancer	0.00121	0.0227	CbGeAlD
Flutamide—Pulmonary embolism—Temozolomide—skin cancer	0.00118	0.00732	CcSEcCtD
Flutamide—Decreased appetite—Vismodegib—skin cancer	0.00116	0.00719	CcSEcCtD
Flutamide—Fatigue—Vismodegib—skin cancer	0.00115	0.00713	CcSEcCtD
Flutamide—Ulcer—Fluorouracil—skin cancer	0.00115	0.00713	CcSEcCtD
Flutamide—AR—connective tissue—skin cancer	0.00115	0.0215	CbGeAlD
Flutamide—Oedema peripheral—Vemurafenib—skin cancer	0.00114	0.00708	CcSEcCtD
Flutamide—Constipation—Vismodegib—skin cancer	0.00114	0.00707	CcSEcCtD
Flutamide—Erectile dysfunction—Imiquimod—skin cancer	0.00114	0.00705	CcSEcCtD
Flutamide—Photosensitivity reaction—Imiquimod—skin cancer	0.00113	0.00699	CcSEcCtD
Flutamide—Interstitial lung disease—Docetaxel—skin cancer	0.00111	0.00687	CcSEcCtD
Flutamide—CYP1B1—skin of body—skin cancer	0.00109	0.0205	CbGeAlD
Flutamide—AR—epithelium—skin cancer	0.00109	0.0204	CbGeAlD
Flutamide—Neoplasm—Temozolomide—skin cancer	0.00107	0.00661	CcSEcCtD
Flutamide—AR—skin of body—skin cancer	0.00103	0.0194	CbGeAlD
Flutamide—Erythema—Vemurafenib—skin cancer	0.00101	0.00626	CcSEcCtD
Flutamide—AHR—lymph node—skin cancer	0.000958	0.018	CbGeAlD
Flutamide—Asthenia—Vismodegib—skin cancer	0.000957	0.00593	CcSEcCtD
Flutamide—Pruritus—Vismodegib—skin cancer	0.000944	0.00585	CcSEcCtD
Flutamide—AR—mammalian vulva—skin cancer	0.000943	0.0177	CbGeAlD
Flutamide—Hot flush—Temozolomide—skin cancer	0.000916	0.00568	CcSEcCtD
Flutamide—Diarrhoea—Vismodegib—skin cancer	0.000913	0.00566	CcSEcCtD
Flutamide—Menopausal symptoms—Temozolomide—skin cancer	0.000909	0.00563	CcSEcCtD
Flutamide—CYP1B1—lymphoid tissue—skin cancer	0.000885	0.0166	CbGeAlD
Flutamide—Erythema—Imiquimod—skin cancer	0.000861	0.00534	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000854	0.00529	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000853	0.00529	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.000853	0.00529	CcSEcCtD
Flutamide—CYP1B1—female reproductive system—skin cancer	0.000853	0.016	CbGeAlD
Flutamide—Vomiting—Vismodegib—skin cancer	0.000848	0.00526	CcSEcCtD
Flutamide—Rash—Vismodegib—skin cancer	0.000841	0.00521	CcSEcCtD
Flutamide—Dermatitis—Vismodegib—skin cancer	0.000841	0.00521	CcSEcCtD
Flutamide—AR—lymphoid tissue—skin cancer	0.000838	0.0157	CbGeAlD
Flutamide—Dermatitis bullous—Fluorouracil—skin cancer	0.000826	0.00512	CcSEcCtD
Flutamide—CYP1A1—epithelium—skin cancer	0.000812	0.0153	CbGeAlD
Flutamide—AR—female reproductive system—skin cancer	0.000808	0.0152	CbGeAlD
Flutamide—Skin disorder—Vemurafenib—skin cancer	0.000801	0.00496	CcSEcCtD
Flutamide—Ill-defined disorder—Imiquimod—skin cancer	0.000799	0.00495	CcSEcCtD
Flutamide—Nausea—Vismodegib—skin cancer	0.000793	0.00491	CcSEcCtD
Flutamide—Pulmonary embolism—Docetaxel—skin cancer	0.000785	0.00487	CcSEcCtD
Flutamide—Malaise—Imiquimod—skin cancer	0.000777	0.00481	CcSEcCtD
Flutamide—CYP1A1—skin of body—skin cancer	0.000772	0.0145	CbGeAlD
Flutamide—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000772	0.00478	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.000772	0.00478	CcSEcCtD
Flutamide—Haematuria—Bleomycin—skin cancer	0.000747	0.00463	CcSEcCtD
Flutamide—Hypertension—Imiquimod—skin cancer	0.000744	0.00461	CcSEcCtD
Flutamide—Anxiety—Imiquimod—skin cancer	0.000731	0.00453	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000728	0.00451	CcSEcCtD
Flutamide—Discomfort—Imiquimod—skin cancer	0.000725	0.00449	CcSEcCtD
Flutamide—Decreased appetite—Vemurafenib—skin cancer	0.000717	0.00444	CcSEcCtD
Flutamide—CYP1B1—head—skin cancer	0.000713	0.0134	CbGeAlD
Flutamide—Fatigue—Vemurafenib—skin cancer	0.000711	0.0044	CcSEcCtD
Flutamide—Neoplasm—Docetaxel—skin cancer	0.00071	0.0044	CcSEcCtD
Flutamide—Constipation—Vemurafenib—skin cancer	0.000705	0.00437	CcSEcCtD
Flutamide—CYP1A1—mammalian vulva—skin cancer	0.000704	0.0132	CbGeAlD
Flutamide—Oedema—Imiquimod—skin cancer	0.000703	0.00436	CcSEcCtD
Flutamide—Skin disorder—Imiquimod—skin cancer	0.000683	0.00423	CcSEcCtD
Flutamide—Erectile dysfunction—Temozolomide—skin cancer	0.000682	0.00423	CcSEcCtD
Flutamide—Photosensitivity reaction—Temozolomide—skin cancer	0.000676	0.00419	CcSEcCtD
Flutamide—AR—head—skin cancer	0.000675	0.0127	CbGeAlD
Flutamide—Anorexia—Imiquimod—skin cancer	0.00067	0.00415	CcSEcCtD
Flutamide—Hyperglycaemia—Temozolomide—skin cancer	0.000668	0.00414	CcSEcCtD
Flutamide—Hepatitis—Dactinomycin—skin cancer	0.000656	0.00406	CcSEcCtD
Flutamide—Insomnia—Imiquimod—skin cancer	0.000636	0.00394	CcSEcCtD
Flutamide—Somnolence—Imiquimod—skin cancer	0.000625	0.00387	CcSEcCtD
Flutamide—Photosensitivity reaction—Fluorouracil—skin cancer	0.000623	0.00386	CcSEcCtD
Flutamide—Erythema—Bleomycin—skin cancer	0.000612	0.00379	CcSEcCtD
Flutamide—Decreased appetite—Imiquimod—skin cancer	0.000611	0.00379	CcSEcCtD
Flutamide—Hot flush—Docetaxel—skin cancer	0.000609	0.00378	CcSEcCtD
Flutamide—Fatigue—Imiquimod—skin cancer	0.000606	0.00376	CcSEcCtD
Flutamide—Menopausal symptoms—Docetaxel—skin cancer	0.000604	0.00374	CcSEcCtD
Flutamide—CYP1A1—female reproductive system—skin cancer	0.000603	0.0113	CbGeAlD
Flutamide—Dermatitis bullous—Docetaxel—skin cancer	0.000596	0.0037	CcSEcCtD
Flutamide—Hepatitis—Temozolomide—skin cancer	0.000593	0.00367	CcSEcCtD
Flutamide—Asthenia—Vemurafenib—skin cancer	0.000592	0.00366	CcSEcCtD
Flutamide—Oedema peripheral—Temozolomide—skin cancer	0.000584	0.00362	CcSEcCtD
Flutamide—Pruritus—Vemurafenib—skin cancer	0.000583	0.00361	CcSEcCtD
Flutamide—Feeling abnormal—Imiquimod—skin cancer	0.000579	0.00359	CcSEcCtD
Flutamide—Erythema—Dactinomycin—skin cancer	0.000571	0.00354	CcSEcCtD
Flutamide—Ill-defined disorder—Bleomycin—skin cancer	0.000568	0.00352	CcSEcCtD
Flutamide—Anaemia—Bleomycin—skin cancer	0.000566	0.0035	CcSEcCtD
Flutamide—Diarrhoea—Vemurafenib—skin cancer	0.000564	0.00349	CcSEcCtD
Flutamide—Malaise—Bleomycin—skin cancer	0.000552	0.00342	CcSEcCtD
Flutamide—Leukopenia—Bleomycin—skin cancer	0.000548	0.00339	CcSEcCtD
Flutamide—Dizziness—Vemurafenib—skin cancer	0.000545	0.00338	CcSEcCtD
Flutamide—Ill-defined disorder—Dactinomycin—skin cancer	0.00053	0.00328	CcSEcCtD
Flutamide—Anaemia—Dactinomycin—skin cancer	0.000528	0.00327	CcSEcCtD
Flutamide—Vomiting—Vemurafenib—skin cancer	0.000524	0.00325	CcSEcCtD
Flutamide—Rash—Vemurafenib—skin cancer	0.00052	0.00322	CcSEcCtD
Flutamide—Dermatitis—Vemurafenib—skin cancer	0.000519	0.00322	CcSEcCtD
Flutamide—Headache—Vemurafenib—skin cancer	0.000516	0.0032	CcSEcCtD
Flutamide—Erythema—Temozolomide—skin cancer	0.000516	0.0032	CcSEcCtD
Flutamide—Discomfort—Bleomycin—skin cancer	0.000515	0.00319	CcSEcCtD
Flutamide—Malaise—Dactinomycin—skin cancer	0.000515	0.00319	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000513	0.00318	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000513	0.00318	CcSEcCtD
Flutamide—Leukopenia—Dactinomycin—skin cancer	0.000511	0.00317	CcSEcCtD
Flutamide—Asthenia—Imiquimod—skin cancer	0.000504	0.00312	CcSEcCtD
Flutamide—CYP1A1—head—skin cancer	0.000504	0.00947	CbGeAlD
Flutamide—Confusional state—Bleomycin—skin cancer	0.000504	0.00312	CcSEcCtD
Flutamide—Oedema—Bleomycin—skin cancer	0.000499	0.00309	CcSEcCtD
Flutamide—CYP1B1—lymph node—skin cancer	0.000499	0.00938	CbGeAlD
Flutamide—Pruritus—Imiquimod—skin cancer	0.000497	0.00308	CcSEcCtD
Flutamide—Nausea—Vemurafenib—skin cancer	0.00049	0.00303	CcSEcCtD
Flutamide—Thrombocytopenia—Bleomycin—skin cancer	0.000489	0.00303	CcSEcCtD
Flutamide—Diarrhoea—Imiquimod—skin cancer	0.000481	0.00298	CcSEcCtD
Flutamide—Discomfort—Dactinomycin—skin cancer	0.00048	0.00297	CcSEcCtD
Flutamide—Ill-defined disorder—Temozolomide—skin cancer	0.000479	0.00297	CcSEcCtD
Flutamide—Anaemia—Temozolomide—skin cancer	0.000477	0.00296	CcSEcCtD
Flutamide—Anorexia—Bleomycin—skin cancer	0.000476	0.00295	CcSEcCtD
Flutamide—Erythema—Fluorouracil—skin cancer	0.000476	0.00295	CcSEcCtD
Flutamide—AR—lymph node—skin cancer	0.000473	0.00888	CbGeAlD
Flutamide—Oedema—Dactinomycin—skin cancer	0.000466	0.00289	CcSEcCtD
Flutamide—Malaise—Temozolomide—skin cancer	0.000466	0.00288	CcSEcCtD
Flutamide—Dizziness—Imiquimod—skin cancer	0.000465	0.00288	CcSEcCtD
Flutamide—Leukopenia—Temozolomide—skin cancer	0.000462	0.00286	CcSEcCtD
Flutamide—Thrombocytopenia—Dactinomycin—skin cancer	0.000456	0.00283	CcSEcCtD
Flutamide—Vomiting—Imiquimod—skin cancer	0.000447	0.00277	CcSEcCtD
Flutamide—Hypertension—Temozolomide—skin cancer	0.000446	0.00276	CcSEcCtD
Flutamide—Anorexia—Dactinomycin—skin cancer	0.000444	0.00275	CcSEcCtD
Flutamide—Rash—Imiquimod—skin cancer	0.000443	0.00275	CcSEcCtD
Flutamide—Dermatitis—Imiquimod—skin cancer	0.000443	0.00274	CcSEcCtD
Flutamide—CYP3A4—female reproductive system—skin cancer	0.000443	0.00832	CbGeAlD
Flutamide—Headache—Imiquimod—skin cancer	0.00044	0.00273	CcSEcCtD
Flutamide—Anaemia—Fluorouracil—skin cancer	0.00044	0.00272	CcSEcCtD
Flutamide—Anxiety—Temozolomide—skin cancer	0.000438	0.00271	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000436	0.0027	CcSEcCtD
Flutamide—Discomfort—Temozolomide—skin cancer	0.000434	0.00269	CcSEcCtD
Flutamide—Decreased appetite—Bleomycin—skin cancer	0.000434	0.00269	CcSEcCtD
Flutamide—Jaundice—Docetaxel—skin cancer	0.000428	0.00265	CcSEcCtD
Flutamide—Leukopenia—Fluorouracil—skin cancer	0.000426	0.00264	CcSEcCtD
Flutamide—Confusional state—Temozolomide—skin cancer	0.000425	0.00263	CcSEcCtD
Flutamide—Oedema—Temozolomide—skin cancer	0.000421	0.00261	CcSEcCtD
Flutamide—Nausea—Imiquimod—skin cancer	0.000418	0.00259	CcSEcCtD
Flutamide—Thrombocytopenia—Temozolomide—skin cancer	0.000413	0.00256	CcSEcCtD
Flutamide—Feeling abnormal—Bleomycin—skin cancer	0.000412	0.00255	CcSEcCtD
Flutamide—Skin disorder—Temozolomide—skin cancer	0.000409	0.00254	CcSEcCtD
Flutamide—Decreased appetite—Dactinomycin—skin cancer	0.000405	0.00251	CcSEcCtD
Flutamide—Fatigue—Dactinomycin—skin cancer	0.000402	0.00249	CcSEcCtD
Flutamide—Anorexia—Temozolomide—skin cancer	0.000402	0.00249	CcSEcCtD
Flutamide—Discomfort—Fluorouracil—skin cancer	0.0004	0.00248	CcSEcCtD
Flutamide—Hepatitis—Docetaxel—skin cancer	0.000394	0.00244	CcSEcCtD
Flutamide—Confusional state—Fluorouracil—skin cancer	0.000391	0.00242	CcSEcCtD
Flutamide—Oedema peripheral—Docetaxel—skin cancer	0.000389	0.00241	CcSEcCtD
Flutamide—Oedema—Fluorouracil—skin cancer	0.000388	0.0024	CcSEcCtD
Flutamide—Feeling abnormal—Dactinomycin—skin cancer	0.000384	0.00238	CcSEcCtD
Flutamide—Insomnia—Temozolomide—skin cancer	0.000381	0.00236	CcSEcCtD
Flutamide—Thrombocytopenia—Fluorouracil—skin cancer	0.00038	0.00235	CcSEcCtD
Flutamide—Somnolence—Temozolomide—skin cancer	0.000375	0.00232	CcSEcCtD
Flutamide—Anorexia—Fluorouracil—skin cancer	0.00037	0.00229	CcSEcCtD
Flutamide—Decreased appetite—Temozolomide—skin cancer	0.000366	0.00227	CcSEcCtD
Flutamide—Fatigue—Temozolomide—skin cancer	0.000363	0.00225	CcSEcCtD
Flutamide—Constipation—Temozolomide—skin cancer	0.00036	0.00223	CcSEcCtD
Flutamide—Asthenia—Bleomycin—skin cancer	0.000358	0.00222	CcSEcCtD
Flutamide—Pruritus—Bleomycin—skin cancer	0.000353	0.00219	CcSEcCtD
Flutamide—CYP1A1—lymph node—skin cancer	0.000353	0.00663	CbGeAlD
Flutamide—Insomnia—Fluorouracil—skin cancer	0.000351	0.00218	CcSEcCtD
Flutamide—Feeling abnormal—Temozolomide—skin cancer	0.000347	0.00215	CcSEcCtD
Flutamide—Somnolence—Fluorouracil—skin cancer	0.000345	0.00214	CcSEcCtD
Flutamide—Erythema—Docetaxel—skin cancer	0.000343	0.00213	CcSEcCtD
Flutamide—Decreased appetite—Fluorouracil—skin cancer	0.000337	0.00209	CcSEcCtD
Flutamide—Asthenia—Dactinomycin—skin cancer	0.000334	0.00207	CcSEcCtD
Flutamide—Feeling abnormal—Fluorouracil—skin cancer	0.00032	0.00198	CcSEcCtD
Flutamide—Diarrhoea—Dactinomycin—skin cancer	0.000319	0.00197	CcSEcCtD
Flutamide—Vomiting—Bleomycin—skin cancer	0.000318	0.00197	CcSEcCtD
Flutamide—Anaemia—Docetaxel—skin cancer	0.000317	0.00197	CcSEcCtD
Flutamide—Rash—Bleomycin—skin cancer	0.000315	0.00195	CcSEcCtD
Flutamide—Dermatitis—Bleomycin—skin cancer	0.000315	0.00195	CcSEcCtD
Flutamide—Leukopenia—Docetaxel—skin cancer	0.000307	0.0019	CcSEcCtD
Flutamide—Asthenia—Temozolomide—skin cancer	0.000302	0.00187	CcSEcCtD
Flutamide—Pruritus—Temozolomide—skin cancer	0.000298	0.00185	CcSEcCtD
Flutamide—Nausea—Bleomycin—skin cancer	0.000297	0.00184	CcSEcCtD
Flutamide—Hypertension—Docetaxel—skin cancer	0.000296	0.00184	CcSEcCtD
Flutamide—Vomiting—Dactinomycin—skin cancer	0.000296	0.00183	CcSEcCtD
Flutamide—Rash—Dactinomycin—skin cancer	0.000294	0.00182	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00029	0.0018	CcSEcCtD
Flutamide—Diarrhoea—Temozolomide—skin cancer	0.000288	0.00179	CcSEcCtD
Flutamide—Confusional state—Docetaxel—skin cancer	0.000283	0.00175	CcSEcCtD
Flutamide—Oedema—Docetaxel—skin cancer	0.00028	0.00174	CcSEcCtD
Flutamide—Dizziness—Temozolomide—skin cancer	0.000279	0.00173	CcSEcCtD
Flutamide—Nausea—Dactinomycin—skin cancer	0.000277	0.00171	CcSEcCtD
Flutamide—Pruritus—Fluorouracil—skin cancer	0.000275	0.0017	CcSEcCtD
Flutamide—Thrombocytopenia—Docetaxel—skin cancer	0.000274	0.0017	CcSEcCtD
Flutamide—Skin disorder—Docetaxel—skin cancer	0.000272	0.00169	CcSEcCtD
Flutamide—Vomiting—Temozolomide—skin cancer	0.000268	0.00166	CcSEcCtD
Flutamide—Anorexia—Docetaxel—skin cancer	0.000267	0.00165	CcSEcCtD
Flutamide—Rash—Temozolomide—skin cancer	0.000266	0.00165	CcSEcCtD
Flutamide—Diarrhoea—Fluorouracil—skin cancer	0.000266	0.00165	CcSEcCtD
Flutamide—Dermatitis—Temozolomide—skin cancer	0.000265	0.00164	CcSEcCtD
Flutamide—Headache—Temozolomide—skin cancer	0.000264	0.00164	CcSEcCtD
Flutamide—Dizziness—Fluorouracil—skin cancer	0.000257	0.00159	CcSEcCtD
Flutamide—Insomnia—Docetaxel—skin cancer	0.000253	0.00157	CcSEcCtD
Flutamide—Nausea—Temozolomide—skin cancer	0.00025	0.00155	CcSEcCtD
Flutamide—Somnolence—Docetaxel—skin cancer	0.000249	0.00154	CcSEcCtD
Flutamide—Vomiting—Fluorouracil—skin cancer	0.000247	0.00153	CcSEcCtD
Flutamide—Rash—Fluorouracil—skin cancer	0.000245	0.00152	CcSEcCtD
Flutamide—Dermatitis—Fluorouracil—skin cancer	0.000245	0.00151	CcSEcCtD
Flutamide—Decreased appetite—Docetaxel—skin cancer	0.000244	0.00151	CcSEcCtD
Flutamide—Headache—Fluorouracil—skin cancer	0.000243	0.00151	CcSEcCtD
Flutamide—Fatigue—Docetaxel—skin cancer	0.000242	0.0015	CcSEcCtD
Flutamide—Constipation—Docetaxel—skin cancer	0.00024	0.00148	CcSEcCtD
Flutamide—Feeling abnormal—Docetaxel—skin cancer	0.000231	0.00143	CcSEcCtD
Flutamide—Nausea—Fluorouracil—skin cancer	0.000231	0.00143	CcSEcCtD
Flutamide—Asthenia—Docetaxel—skin cancer	0.000201	0.00125	CcSEcCtD
Flutamide—Pruritus—Docetaxel—skin cancer	0.000198	0.00123	CcSEcCtD
Flutamide—Diarrhoea—Docetaxel—skin cancer	0.000192	0.00119	CcSEcCtD
Flutamide—Dizziness—Docetaxel—skin cancer	0.000185	0.00115	CcSEcCtD
Flutamide—Vomiting—Docetaxel—skin cancer	0.000178	0.0011	CcSEcCtD
Flutamide—Rash—Docetaxel—skin cancer	0.000177	0.00109	CcSEcCtD
Flutamide—Dermatitis—Docetaxel—skin cancer	0.000177	0.00109	CcSEcCtD
Flutamide—Headache—Docetaxel—skin cancer	0.000176	0.00109	CcSEcCtD
Flutamide—Nausea—Docetaxel—skin cancer	0.000166	0.00103	CcSEcCtD
